Quantcast

PTC Therapeutics Shows Market Leadership With Jump To 84 RS Rating


Shutterstock photo

When putting together your watch list, focus on stocks with an 80 or higher RS Rating . PTC Therapeutics ( PTCT ) is one stock that just reached the mark, now earning a score of 84.

[ibd-display-video id=2102289 width=50 float=left autostart=true] This unique rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matches up against other publicly traded companies.

Over 100 years of market history shows that the market's biggest winners tend to have an RS Rating of over 80 in the early stages of their moves.

Looking For Winning Stocks? Try This Simple Routine

PTC Therapeutics is working on a consolidation with a 22.10 buy point . See if it can clear the breakout price in heavy volume.

Earnings growth rose in the company's latest report from 0% to 20%, but sales fell from 207% to 82%.

PTC Therapeutics earns the No. 94 rank among its peers in the Medical-Biomed/Biotech industry group. Corcept Therapeutics ( CORT ), Vertex Pharmaceuticals ( VRTX ) and Ligand Pharmaceuticals ( LGND ) are among the top 5 highly rated stocks within the group.

RELATED:

Biotech And Pharmaceutical Industry And Stock News

Which Stocks Are Showing Improved Price Performance?

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: Investing , Stocks
Referenced Symbols: PTCT , CORT , VRTX , LGND



More from Investor's Business Daily

Subscribe






Investor's Business Daily
Contributor:

Investor's Business Daily

Investing










Research Brokers before you trade

Want to trade FX?